Scientific Publication

Effect of WHO stage 3/4 events after ART initiation on survival of HIV-infected African adults in the DART trial

author(s) Grosskurth, H.. - Walker, A.S.. - Kityo, C.. - Gilks, C.F.. - Munderi, P.. - Hakim, J.. - Gibb, D.M.. - Ssali, F.. - Reid, A.. - Ford, D.. - Lutwama, F.. - Babiker, Ag.
from UK Foreign, Commonwealth & Development Office (FCDO)
permalink open
themes
regions
  • Northern America
  • Americas
  • World
  • Eastern Africa
  • Sub-Saharan Africa
  • Africa
citation

Kityo, C.; Ford, D.; Walker, A.S.; Hakim, J.; Munderi, P.; Lutwama, F.; Ssali, F.; Reid, A.; Grosskurth, H.; Gibb, D.M.; Gilks, C.F.; Babiker, Ag. Effect of WHO stage 3/4 events after ART initiation on survival of HIV-infected African adults in the DART trial. Presented at the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Cape Town, South Africa, 19-22 July 2009. (2009) 1 pp

Publications and datasets provided via GARDIAN

Abstract

The objective of the study reported in this conference poster was to estimate mortality risks following a WHO 3/4 event according to diagnosis in individuals starting triple drug antiretroviral therapy (ART) in Africa. WHO stage 3/4 events are often used to determine success/failure of ART in middle/low-income settings where access to laboratory measurements is limited. The trial design; patients, follow-up and data; methods, WHO 3/4 events after ART initiation; risk of death in weeks 0-36 on ART, risk of death after 36 weeks on ART; estimated causal risks of death after a WHO 3/4 event after 36 weeks on ART; and conclusions are presented

Open original